Ashwini Arjuna

Ashwini Arjuna

Auto-generated profile, based on publicly available information

Ashwini Arjuna

Norton Thoracic Institute, St. Joseph’s Hospital and Medical Center, Phoenix, Arizona, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2020 in Expert Review of Respiratory Medicine
Verified
Journal Article
Closed access
AAAshwini Arjuna
Ashwini Arjuna
MOMichael T. Olson
Michael T. Olson
RWRajat Walia
Rajat Walia
RBRoss M. Bremner
Ross M. Bremner
MSMichael A. Smith
Michael A. Smith
TMThalachallour Mohanakumar
Thalachallour Mohanakumar
Bronchiolitis obliterans syndrome (BOS), a subtype of chronic lung allograft dysfunction, is quite common, with up to half of all lung recipients developing BOS within 5 years of transplantation. P...

30 September 2020 in Transplant Infectious Disease
Verified
Journal Article
Open access
PDF file
KGKellie J. Goodlet
Kellie J. Goodlet
SBSandhya Bansal
Sandhya Bansal
AAAshwini Arjuna
Ashwini Arjuna
MNMichael D. Nailor
Michael D. Nailor
BBBhuvin Buddhdev
Bhuvin Buddhdev
STSofya Tokman
Sofya Tokman
Exosomes isolated from plasma of lung transplant recipients with allograft injury contain donor‐derived lung self‐antigens (collagen V and Kα1 tubulin) and human leukocyte antigen (HLA) molecules. We present a case of a 76‐year‐old, female lung transplant recipient treated for acute cellular rejection with methylprednisolone and anti‐thymocyte globulin, who subsequently contracted SARS‐CoV‐2 and developed a sharp increase in the mean fluorescent intensity of anti‐HLA antibodies. Analysis of circulating exosomes during rejection, but before SARS‐CoV‐2 infection, revealed the presence of lung self‐antigens and HLA class II molecules. After the patient contracted SARS‐CoV‐2, exosomes with the SARS‐CoV‐2 spike protein were also found. After resolution of infectious symptoms, exosomes with SARS‐CoV‐2 spike protein were no longer detected; however, exosomes with lung self‐antigens and HLA class II molecules persisted, which coincided with a progressive decline in spirometric flows, suggesting chronic lung allograft dysfunction. We propose that the analysis of circulating exosomes may be used to detect allograft injury mediated by both rejection and infection. Furthermore, the detection of exosomes containing viral proteins may be helpful in identifying allograft injury driven by viral pathogens.

2 May 2022 in Thoracic Surgery Clinics
Verified
Journal Article
Closed access
AAAshwini Arjuna
Ashwini Arjuna
AMAnna Teresa Mazzeo
Anna Teresa Mazzeo
TTTommaso Tonetti
Tommaso Tonetti
RWRajat Walia
Rajat Walia
LMLuciana Mascia
Luciana Mascia

16 October 2023 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
DSDevika Sindu
Devika Sindu
DRDeepika Razia
Deepika Razia
CBCurt Bay
Curt Bay
JPJosna Padiyar
Josna Padiyar
KGKatherine Grief
Katherine Grief
STSofya Tokman
Sofya Tokman

3 March 2022 in Journal of Transplantation
Verified
Journal Article
Open access
PDF file
DRDeepika Razia
Deepika Razia
STSofya Tokman
Sofya Tokman
SISharjeel Israr
Sharjeel Israr
HMHesham Mohamed
Hesham Mohamed
HAHesham Abdelrazek
Hesham Abdelrazek
AOAshraf Omar
Ashraf Omar
Background. Persistent orthostatic hypotension (OH) is a lesser-known complication of lung transplantation (LTx). In this retrospective case series, we describe the clinical manifestations, complications, and treatment of persistent OH in 13 LTx recipients. Methods. We identified LTx recipients who underwent transplantation between March 1, 2018, and March 31, 2020, with persistent symptomatic OH and retrospectively queried the records for clinical information. Results. Thirteen patients were included in the analysis, 9 (69) had underlying pulmonary fibrosis, and 12 (92) were male. The median age, height, and body mass index at LTx were 68 years, 70 inches, and 27kg/m2, respectively. Six (46) patients were deceased at the time of chart abstraction with a median (IQR) posttransplant survival of 12.6 months (6, 21); the 7 remaining living patients were a median of 19.6 months (18, 32) posttransplant. Signs and symptoms of OH developed a median of 60 (7, 75) days after transplant. Patients were treated with pharmacological agents and underwent extensive physical therapy. Most patients required inpatient rehabilitation (n=10, 77), and patients commonly developed comorbid conditions including weight loss, renal insufficiency with eGFR <50 (n=13, 100), gastroparesis (n=7, 54), and tachycardia-bradycardia syndrome (n=2, 15). Falls were common (n=10, 77). The incidence of OH in LTx recipients at our center during the study period was 5.6 (13/234). Conclusions. Persistent OH is a lesser-known complication of LTx that impacts posttransplant rehabilitation and may lead to comorbidities and shortened survival. In addition, most LTx recipients with OH at our center were tall, thin men with underlying pulmonary fibrosis, which may offer an opportunity to instate pretransplant OH screening of at-risk patients.

1 December 2025 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Open access
RKRachel Klein
Rachel Klein
JBJonathan Braat
Jonathan Braat
AAAshwini Arjuna
Ashwini Arjuna
MPMegan Paternoster
Megan Paternoster
MSMichael Smith
Michael Smith
DSDavide Scozzi
Davide Scozzi
Primary Graft Dysfunction (PGD) is an early post-lung transplant (LTx) inflammatory condition primarily driven by lung ischemia-reperfusion injury (LIRI). Neutrophils are key mediators of LIRI, but their phenotypic diversity and maturation state remain poorly characterized. In other inflammatory settings, early expansion of immature neutrophils has been linked to increased tissue injury and worse clinical outcomes. Whether immature neutrophils increase following LTx and contribute to PGD severity remains unclear. Circulating neutrophil heterogeneity was analyzed by flow cytometry in 20 LTx candidates with advanced lung disease and 30 LTx recipients. Matched plasma samples were used for cytokine profiling. The role of immature neutrophils in LIRI was studied using a murine left pulmonary hilar clamp model with or without anti-G-CSF treatment. The differentiation and effector functions of immature neutrophils derived from murine hematopoietic progenitors were studied in vitro. LTx recipients exhibited an early rise in circulating immature neutrophils, correlated with higher G-CSF levels and PGD severity. In mice, LIRI was linked to increased G-CSF levels, significant mobilization, and lung infiltration of immature neutrophils with an activated, ROS-producing phenotype. These cells showed prolonged survival, strong ROS activity, but impaired phagocytosis. Preoperative anti-G-CSF treatment decreased lung injury while reducing immature neutrophil mobilization and recruitment to the lung. Our findings underscore the clinical significance of neutrophil heterogeneity in the early perioperative setting following LTx. Targeting the G-CSF-immature neutrophil axis may offer a novel strategy to improve early lung allograft outcomes.